Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer. Cortellini A, D'Alessio A, Cleary S, Buti S, et al. Clin Cancer Res 2023;29:2714-2724.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cortellini A, D'Alessio A, Cleary S, Buti S, et al. Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer. Clin Cancer Res 2023;29:2714-2724.
PMID: 37125965